Viewing data from:

GANCICLOVIR

ANDA

GANCICLOVIR | A076457 | RANBAXY LABORATORIES LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

EXCELLA GMBH AND CO KGGANCICLOVIR

DMF 155672001

SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO LTDGANCICLOVIR

DMF 289732015

APITORIA PHARMA PRIVATE LTDGANCICLOVIR USP

DMF 314022017

RANBAXY LABORATORIES LTDInactiveGANCICLOVIR

DMF 160432002

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveGANCICLOVIR (INTERMEDIATE DRUG SUBSTANCE)

DMF 190492005

EXCELLA GMBHInactiveGANCICLOVIR ANHYDROUS R

DMF 243372010

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDInactiveGANCICLOVIR USP (NON-STERILE API)

DMF 271332013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 250MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jun 27, 2003

No patent or exclusivity listings for this strength.

#002 — 500MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 27, 2003